FDA Classifies Neuromuscular Tongue Muscle Stimulator for Snoring and Sleep Apnea Reduction

Summary

The US Food and Drug Administration (FDA) has classified the neuromuscular tongue muscle stimulator for reducing snoring and obstructive sleep apnea into Class II, requiring special controls to ensure its safety and effectiveness. This move aims to enhance patients' access to innovative devices.